For the second time this week, North Carolina has awarded an economic incentive to a manufacturer that promises to add ...

President Donald Trump's plans to dramatically slash drug prices for Americans could make Swiss pharmaceutical giant Roche ...

More than $13 million in incentives from North Carolina are pledged to a biotech company making a $700 million investment, a ...

Roche envisions its Indianapolis site as a “major hub” for the manufacturing of its continuous glucose monitoring systems.

AS Monaco and Roche Bobois, a French brand specializing in high-end furnishings and decoration with an international ...

Greentech and Roche are planning domestic manufacturing facilities, adding to the list of projects sparked by Trump's push ...

Governor Josh Stein announced Monday that Genentech, one of the world’s premiere biotechnology companies, will invest $700 ...

Genentech plans to invest $700 million in a new facility in Holly Springs, North Carolina, creating 420 jobs and joining the ...

The U.S. secured over $1 billion in new manufacturing investment today on the back of President Trump’s push for more domestic production. Receive undervalued stocks, resilient to market uncertainty, ...

Roche plans to invest as much as $550 million in its Indianapolis diagnostics campus during the next five years, with plans to build it into a U.S. | The announcement follows a five-year, $50 billion ...

Genentech, a Bay Area-based biotech firm and member of the Switzerland-based Roche Group, plans to develop a $700 million pharmaceutical manufacturing facility in Holly Springs, approximately 20 miles ...